SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC
http://www.w3.org/2000/01/rdf-schema#comment
"Rodent and human tumor cells containing constitutively activated Raf/Raf/MEK/ERK pathways were resistant to mda-5-induced killing."
xsd:string
http://purl.uniprot.org/uniprot/#_5DC1E5C01876AB5AAA6993172A23D8E590526E7E73578C148C6D717A10102F939E1C97E9CDC0DC3053AD8A78C7F6B2D8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC
http://purl.uniprot.org/uniprot/Q9BYX4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC
http://purl.uniprot.org/uniprot/#_Q9BYX4-mappedCitation-16575407
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/64A21034648DE21A539A3E73079C304D51BC13098D41AFB9A5670ED81F7494881818ACE661E5EA95DD4AF236FA8463AC